发明名称 |
PHARMACEUTICAL COMPOSITION COMPRISING N-[3-CHLORO-4-(3-FLUOROBENZYLOXY)PHENYL]-6-[5({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURYL]QUINAZOLIN-4-AMINE OR A PHARMACEUTICALLY ACCEPTABLE SALT, SOLVATE OR SOLVATED SALT THEREOF |
摘要 |
The present invention relates to a pharmaceutical composition comprising N-[3-chloro-4-(3-fluorobenzyloxy)phenyl]-6-[5({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]quinazolin-4-amine or a pharmaceutically acceptable salt, solvate or solvated salt thereof, and a process for preparing the pharmaceutical composition. |
申请公布号 |
WO2014128107(A1) |
申请公布日期 |
2014.08.28 |
申请号 |
WO2014EP53087 |
申请日期 |
2014.02.18 |
申请人 |
HEXAL AG |
发明人 |
ROTHER, PATRICK |
分类号 |
A61K9/16;A61K9/20;A61K9/28 |
主分类号 |
A61K9/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|